Background: Reactive oxygen species play critical roles in homeostasis and cell signaling. Dexmedetomidine, a specific agonist of the α2-adrenoceptor, has been commonly used for sedation, and it has been reported to have a protective effect against oxidative stress. In this study, we investigated whether dexmedetomidine has a protective effect against H2O2-induced oxidative stress and the mechanism of H2O2-induced cell death in normal human fetal osteoblast (hFOB) cells. Methods: Cells were divided into three groups: control group-cells were incubated in normoxia without dexmedetomidine, hydrogen peroxide (H2O2) group-cells were exposed to H2O2 (200 μM) for 2 h, and Dex/H2O2 group-cells were pretreated with dexmedetomidine (5 μM) for 2 h then exposed to H2O2 (200 μM) for 2 h. Cell viability and apoptosis were evaluated. Osteoblast maturation was determined by assaying bone nodular mineralization. Expression levels of bone-related proteins were determined by western blot. Results: Cell viability was significantly decreased in the H2O2 group compared with the control group, and this effect was improved by dexmedetomidine. The Hoechst 33342 and Annexin-V FITC/PI staining revealed that dexmedetomidine effectively decreased H2O2-induced hFOB cell apoptosis. Dexmedetomidine enhanced the mineralization of hFOB cells when compared to the H2O2 group. In western blot analysis, bone-related protein was increased in the Dex/H2O2 group. Conclusions: We demonstrated the potential therapeutic value of dexmedetomidine in H2O2-induced oxidative stress by inhibiting apoptosis and enhancing osteoblast activity. Additionally, the current investigation could be evidence to support the antioxidant potential of dexmedetomidine in vitro.
INTRODUCTION
Oxidative stress is related to an imbalance between the production of reactive oxygen species (ROS) and free radicals as well as inappropriate antioxidant function.
The ROS, formed by an inadequate one-electron defect of oxygen, play critical roles in homeostasis and cell signaling. Hydrogen peroxide (H 2 O 2 ), a highly reactive ROS, has been commonly used to mimic in vitro oxidative stress in many types of cells [1, 2] .
Bone is an essential structure to support the body and has its own homeostatic activity to maintain its integrity.
This activity has been called a bone remodeling process regulated by the balanced action of osteoblasts and osteoclasts [3, 4] . Osteoblasts, which produce and release matrix proteins, have a critical role in the process of bone formation. Intracellular accumulation of ROS in osteoblasts leads to the destruction of bone homeostasis [5] .
Dexmedetomidine, a specific agonist of the α2-adrenoceptor, has been commonly used in operating rooms and intensive care units for analgesia and sedation [6, 7] . Recently, dexmedetomidine has been reported to have a protective effect on the lung, intestine, liver, and kidney against the oxidative stress that is triggered by endotoxemia or ischemia reperfusion [8] [9] [10] [11] .
Thus, we aimed to investigate whether dexmedetomidine has a protective effect against H2O2-induced oxidative stress and to elucidate the mechanism of H 2 O 2 -induced cell death in normal human fetal osteoblast (hFOB) cells.
MATERIALS AND METHODS

Reagents
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) was purchased from Sigma (St. Louis, MO, USA). Antibodies against Collagen type I (Col I), bone morphogenetic protein-2 (BMP-2), osterix, and transforming growth factor-β (TGF-β) were purchased from Abcam (Cambridge, MA, USA). GAPDH, mouse anti-rabbit IgG antibody, and rabbit anti-mouse IgG antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All other chemicals and reagents were purchased from Sigma unless otherwise specified.
Cell culture
Human fetal osteoblast cell line (hFOB 1.19) was purchased from ATCC (Rockville, MD, USA). Cells were cultured in Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F-12) with 4 mM L-glutamine, 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, and 1.0 mM sodium pyruvate supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (GIBCO-BRL, Rockville, MD, USA). Cells were incubated at 37°C in a humidified 5% CO 2 -95% air incubator.
Treatment of dexmedetomidine
The stock of dexmedetomidine (490 μM) was kept 
Cell viability assay
The viability of hFOB cells was determined using the MTT assay. Cells were cultured in 96-well plates (4 × under an epifluorescence microscope (Carl Zeiss, Goettingen, Germany).
Flow cytometer analysis
Quantification of apoptotic cells was determined by 
Alizarin red S staining
Mineralization of hFOB cells was determined in 24-well plates using Alizarin red S (Sigma, St. Louis, MO, USA) staining. The cells were washed once with distilled water after fixation with 4% paraformaldehyde and then stained with 2% alizarin red solution according to the manufacturer's protocol.
Western blot analysis
The cells (1.5 × 10 6 ) were washed twice in ice-cold PBS, resuspended in 200 μl ice-cold solubilizing buffer (300 mM NaCl, 50 mM Tris-Cl (pH 7.6), 0.5 % Triton X-100, 2 mM PMSF, 2 μl/ml aprotinin, and 2 μl/ml leupeptin), and incubated at 4°C for 1 h. 
Statistical analysis
The data are expressed as mean ± SE. The statistical significance between groups was analyzed using one-way analysis of variance and a Dunnett's comparison.
Probability (P) values of less than 0.05 were considered statistically significant.
RESULTS
Dexmedetomidine inhibits H 2 O 2 -induced cell death in hFOB cells
The effect of dexmedetomidine on hFOB cells was demonstrated over various concentrations (0, 0.1, 1, 5, and 10 μM). The viability of hFOB cells pretreated with dexmedetomidine was not changed compared to the Fig. 2 . Human fetal osteoblast (hFOB) cells were pretreated with dexmedetomidine (Dex, 5 μM) for 2 h and then treated with 200 μM of H2O2 for 2 h. Cell viability was analyzed using the MTT assay. The data were calculated as a percentage of the control group and expressed as the mean of at least three experiments. Cell viability was markedly decreased in the H2O2 treatment group compared to the control, but viability was significantly improved by dexmedetomidine. *P < 0.05 compared with the control group, † P < 0.05 compared with the H2O2 group. control. Dexmedetomidine did not show any cytotoxic effect on the hFOB cells (Fig. 1A) . In contrast, after treatment with a wide range of H 2 O 2 concentrations (0, 25, 50, 100, 200, and 400 μM) for 2 h, the cell viability was significantly decreased in a dose-dependent manner (Fig. 1B) . All subsequent experiments were performed with 5 μM of dexmedetomidine and 200 μM of H2O2.
To compare the cell viability among the three groups, we performed another MTT assay. We pretreated with 5 μM of dexmedetomidine for 2 h and then exposed hFOB cells to 200 μM H 2 O 2 for 2 h. As shown in Fig.   2 , cell viability was markedly decreased in the H2O2 group compared to the control, while viability was significantly improved by dexmedetomidine pretreatment.
As a result, we discovered that dexmedetomidine pretreatment significantly protected the hFOB cells from H 2 O 2 -induced cell death. 
Dexmedetomidine protected hFOB cells
Positive effects of dexmedetomidine on mineralization of hFOB cells.
Mineralization of hFOB cells was investigated using
Alizarin red S staining. This staining clearly showed that dexmedetomidine pretreatment enhanced the staining intensity of hFOB cells when compared to that of the H 2 O 2 group (Fig. 5 ).
Effect of dexmedetomidine on expression of bonerelated protein in hFOB cells.
We examined the activation of bone-related protein in hFOB cells by western blotting analysis. The recruitment of osterix to the membrane occurs via a Col I-dependent mechanism; thus, Col I is essential for bone formation in vivo. The levels of Col I, BMP-2, osterix, and TGF-β were increased in the Dex/H 2 O 2 group compared to the H 2 O 2 group (Fig. 6 ).
DISCUSSION
Various external stimuli can trigger oxidative stress by toxins, ischemia, or mechanical stress. Oxidative stress has previously been regarded as an inducer of a variety of bone diseases including osteoblastic apoptosis and osteoporosis [12, 13] . However, the biological mechanism through which oxidative stress affects osteoblast death is still not fully understood.
The goals of this study were to determine the protective effect of dexmedetomidine on hFOB cells that have undergone H2O2-induced oxidative stress and to investigate the regulation of bone homeostasis. Our findings showed that dexmedetomidine treatment did not cause any cytotoxic effects in hFOB cells (Fig. 1A) . We also The ability of PI to enter a cell is dependent on the membrane permeability; PI cannot get into live or early apoptotic cells because of the intact cell membrane. In late-stage apoptosis and necrotic cells, the intact part of plasma and nuclear membranes deteriorates, allowing PI to enter the membranes and display fluorescence [15] [16] [17] [18] [19] [20] .
In the H 2 O 2 group, the portion of Annexin-V(+)/PI(+) cells was increased. This suggested that H2O2 affects the late stage of apoptosis and dexmedetomidine has a protective effect against H 2 O 2 -induced apoptosis in hFOB cells (Fig. 4) .
Osteoblasts, derived from mesenchymal stem cells, are responsible for the formation of bone extracellular matrix and are able to mineralize into bone matrix [21] [22] [23] .
Alizarin red S staining suggested that the bone mineralization matrix was weak in H 2 O 2 groups. As expected, dexmedetomidine pretreatment enhanced the mineralization staining (Fig. 5) . Next, we examined the recovery effect of dexmedetomidine on the expression levels of osteoblastic differentiation markers (Col I, BMP-2, osterix, and TGF-β) in hFOB cells by western blot analysis. Expression of all osteoblastic markers was decreased in the H2O2 group while dexmedetomidine enhanced their expression (Fig. 6 ).
In conclusion, our results suggest that 
